Robert B. Scharpf
Cited by
Cited by
Tackling the widespread and critical impact of batch effects in high-throughput data
JT Leek, RB Scharpf, HC Bravo, D Simcha, B Langmead, WE Johnson, ...
Nature Reviews Genetics 11 (10), 733-739, 2010
Neoadjuvant PD-1 blockade in resectable lung cancer
PM Forde, JE Chaft, KN Smith, V Anagnostou, TR Cottrell, MD Hellmann, ...
New England Journal of Medicine 378 (21), 1976-1986, 2018
Genome-wide association study of blood pressure and hypertension
D Levy, GB Ehret, K Rice, GC Verwoert, LJ Launer, A Dehghan, ...
Nature genetics 41 (6), 677-687, 2009
Direct detection of early-stage cancers using circulating tumor DNA
J Phallen, M Sausen, V Adleff, A Leal, C Hruban, J White, V Anagnostou, ...
Science translational medicine 9 (403), eaan2415, 2017
Genome-wide cell-free DNA fragmentation in patients with cancer
S Cristiano, A Leal, J Phallen, J Fiksel, V Adleff, DC Bruhm, S Jensen, ...
Nature 570 (7761), 385-389, 2019
Evolution of neoantigen landscape during immune checkpoint blockade in non–small cell lung cancer
V Anagnostou, KN Smith, PM Forde, N Niknafs, R Bhattacharya, J White, ...
Cancer discovery 7 (3), 264-276, 2017
Multiple loci associated with indices of renal function and chronic kidney disease
A Kttgen, NL Glazer, A Dehghan, SJ Hwang, R Katz, M Li, Q Yang, ...
Nature genetics 41 (6), 712-717, 2009
High grade serous ovarian carcinomas originate in the fallopian tube
SI Labidi-Galy, E Papp, D Hallberg, N Niknafs, V Adleff, M Noe, ...
Nature communications 8 (1), 1093, 2017
Detectable clonal mosaicism from birth to old age and its relationship to cancer
CC Laurie, CA Laurie, K Rice, KF Doheny, LR Zelnick, CP McHugh, ...
Nature genetics 44 (6), 642-650, 2012
Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients.
Nature Communications 6, 2015
The genomic landscape of response to EGFR blockade in colorectal cancer
A Bertotti, E Papp, S Jones, V Adleff, V Anagnostou, B Lupo, M Sausen, ...
Nature 526 (7572), 263-267, 2015
Dynamics of tumor and immune responses during immune checkpoint blockade in non–small cell lung cancer
V Anagnostou, PM Forde, JR White, N Niknafs, C Hruban, J Naidoo, ...
Cancer research 79 (6), 1214-1225, 2019
Pre-processing Agilent microarray data
M Zahurak, G Parmigiani, W Yu, RB Scharpf, D Berman, E Schaeffer, ...
BMC bioinformatics 8, 1-13, 2007
Detection and characterization of lung cancer using cell-free DNA fragmentomes
D Mathios, JS Johansen, S Cristiano, JE Medina, J Phallen, KR Larsen, ...
Nature communications 12 (1), 5060, 2021
Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer models
H Kim, H Xu, E George, D Hallberg, S Kumar, V Jagannathan, ...
Nature communications 11 (1), 3726, 2020
White blood cell and cell-free DNA analyses for detection of residual disease in gastric cancer
A Leal, NCT van Grieken, DN Palsgrove, J Phallen, JE Medina, C Hruban, ...
Nature communications 11 (1), 525, 2020
Multimodal genomic features predict outcome of immune checkpoint blockade in non-small-cell lung cancer
V Anagnostou, N Niknafs, K Marrone, DC Bruhm, JR White, J Naidoo, ...
Nature cancer 1 (1), 99-111, 2020
Regulation of platelet granule exocytosis by S-nitrosylation
CN Morrell, K Matsushita, K Chiles, RB Scharpf, M Yamakuchi, ...
Proceedings of the National Academy of Sciences 102 (10), 3782-3787, 2005
Genomic characterization of malignant progression in neoplastic pancreatic cysts
M No, N Niknafs, CG Fischer, WM Hackeng, V Beleva Guthrie, ...
Nature communications 11 (1), 4085, 2020
Leukocytes Can Enhance Platelet-mediated Aggregation and Thromboxane Release via Interaction of P-selectin Glycoprotein Ligand 1 with P-selectin
N Faraday, RB Scharpf, JM Dodd-o, EA Martinez, BA Rosenfeld, ...
The Journal of the American Society of Anesthesiologists 94 (1), 145-151, 2001
The system can't perform the operation now. Try again later.
Articles 1–20